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ABSTRACT: Diabetes epidemics pose a serious health care problems and a huge burden on the economy of both 
developed and developing nations. Precise prognosis and the discovery of cost effective drugs for its management would 
serve as catalyst to economic recovery.   This study is aimed at evaluating the prognosis of diabetes complications and the 
efficacy of Guiera senegalensis aqueous leaf extract in streptozotocin (STZ) induced-diabetic rats. Twelve (12) adult male 
Wistar rats were used in this study. Diabetes was induced by administration of 60 mg/kg of streptozotocin. Diabetic rats 
were treated orally with the aid of a gavage 500 mg/kg of aqueous extract of Guiera senegalensis for 21 days. Fasting 
blood glucose and body weight were monitored at intervals of 7 days. Some antioxidant enzymes, lipid profile and indices 
of renal function were assayed after the 21st day. Post administration of 60 mg/kg of STZ produced significant (P<0.05) 
increases in fasting blood glucose, total cholesterol, triglycerides, Na+, and K+ levels. Body weight, catalase and HDL-
cholesterol levels were reduced. Related biochemical indices (superoxide dismutase, glutathione peroxidase, LDL-
cholesterol, urea, creatinine, Cl− and bicarbonate) were similarly modulated by STZ but the effects were not significant 
relative tothe normal control. Administration of extract of Guiera senegalensis reverses the effects of STZ on these 
parameters. Although they were not completely brought back to normal in some cases. These findings are indications that 
Guiera senegalensis has the capacity to attenuate some complications of diabetes mellitus and could be considered as a 
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The burden of non-communicable diseases (NCDs): is 
on the increase in both high- and low-income nations 
(Lozano et al., 2010). Of note, diabetes mellitus has 
drawn public attention for its increasing 
prevalence.The increasing global prevalence of 
diabetes mellitus have led to the disease being 
described as “one of the main threats to human health 
in the twenty-first century” (Tietz, 2008). The disease 
is recognized as an important cause of premature death 
and disability (WHO, 2016) due to its 
complications.Persisting hyperglycemia is a 
forerunner of the various complications (damage and 
failure of different organs such as heart, kidney, eyes, 
nerve etc) of diabetes mellitus, leading to imbalances 
in some biochemical indices: lipid profile, antioxidant 
enzymes, electrolytes etc (Irfan et al., 
2015).Assessment of the levels of these biochemical 
indices could be used as diagnosis and prognosis of the 
disease.Precise prognosis and the discovery of cost 
effective drugs are sine qua non to effective 
management of the disease.Guiera senegalensis, is a 
popular medicinal plant grown in west Africa. It is 
commonly called “Sabara” among the Hausas of the 
northern Nigeria, where decoction of it is used to lower 
blood glucose. Mohammed (2013) and Salihu and 
Usman (2015) havereported the presence of 
pharmacological important phytochemical in the plant. 
The plant has also been reported to be harmless to the 
liver at low dosage (Oshobu and Geidam 2014).This 
study is therefore aimed at evaluating the therapeutic 
potential of the plant on diabetes and its resultant 
complications in Wistar rats.  
 
MATERIALS AND METHODS 
Sample collection: The leaves of the plant, Guiera 
senegalensis were procured from Runka village, in 
Dutsinma LGA of Katsina State. They were identified 
in the Herbarium unit of Biological Science 
Department, Ahmadu Bello University Zaria, Kaduna 
State, Nigeria. And the voucher number (1823) was 
kept in the unit. 
 
Preparation of extract:The extraction was carried out 
according to the method described by Osibemhe et al. 
(2016) with little modifications. Gueira senegalensis 
leaves procured were washed and dried under shade 
for two weeks. They were pulverised into powder 
using mortar and pestle. Measured quantity of the 
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powdered plant sample was macerated in distilled 
water for 72 hours and kept in refrigerator to avoid 
microbial contamination. The solution was 
occasionally stirred. Then it was filtered using Cheese 
cloth and the filtrate was re-filtered with filter paper. It 
was then concentrated using water bath at 500c. And 
the slurry obtained was kept in a desiccator containing 
desiccant (silica gel) for complete absorption of water. 
 
Animals: Fifteen (15) male adult rats (Wistar strain) 
were used for this study. The rats were purchased from 
University of Ibadan, Oyo State. The animals were 
kept under standard conditions for 2 weeks to allow 
them to acclimatize to the new environment and were 
allowed free access to water and food (Vital Feeds, 
Bukuru, Jos, Nigeria) ad libitum. They were handled 
with care in accordance with the internationally 
accepted practices for use and care of laboratory 
animals as contained in US guidelines (NIH, 1992). 
 
Streptozotocin induction: Induction of diabetes was 
then carried out by single intra-peritoneal injection of 
60 mg/kg of streptozotocin (Sigma St Louis, M.O., 
USA) dissolved in 0.9% normal saline to overnight 
fasted rats using  insulin syringe. Diabetes mellitus 
was confirmed after the 10th day of streptozotocin 
treatment by the observation of fasting blood glucose 
(FBG) >300 mg/dl using Glucometer (accu-check). 
 
Experimental design: A total of Fifteen (15) adult rats 
(Wistar strain) were used. The rats were randomly 
selected into three (3) groups of five (5) rats per group. 
One group served as normal control and was given 
distilled water, another group served as diabetic 
control and also received distilled water while the 
other group, diabetic treated, received 500 mg/kg of 
aqueous extract of Guiera senegalensis for a period of 
21 days. Administration was carried out with the aid of 
a gavage. Fasting blood glucose and body weight 
measurements were carried out at intervals of 7days. 
At the end of 21day, the animals were sacrificed and 
blood was collected for the analyses of biochemical 
parameters. 
 
Blood collection: At the end of the 21st day, the rats 
were fasted overnight. Through the abdominal aorta 
using 5 ml syringe, blood sample was collected into 
plain containers from rats under chloroform 
anaesthesia. The blood sample was centrifuge at 3000 
rpm for 15 minutes after which the serum was kept in  
clean plain sample bottles for analyses of kidney 
function indices (urea, creatinine and some 
electrolytes-Sodium (Na+), (Potassium (k+), Chloride 
(Cl-) and Bi-carbonate (HCO3-)), Some antioxidant 
enzymes (Catalase (CAT), superoxide dismutase 
(SOD), glutathione peroxidase (GPX)) and lipid 
profile (Triglycerides, total cholesterol, HDL-
cholesterol and LDL-cholesterol). 
 
Biochemical analysis: Fasting blood glucose was 
analysed using glucometer (accu-check). Lipid profile 
and kidney function indices were assayed using 
standard laboratory kits (Randox). CAT, SOD, and 
GPX were assayed using standard methods of Cohen 
et al. (1970), Misra and Fridovich (1972) and Maehly 
and Chance (1954) respectively. 
 
Statistical analysis: The results are expressed as means 
± SEM of five independent determinations. The means 
were compared by one-way ANOVA followed by 
Duncan post hoc test. Value of P less than 5% (P<0.05) 
was considered statistically significant. 
 
RESULTS AND DISCUSSION 
Fasting blood glucose (Table 1): A lot of reports have 
been documented in literature about medicinal plants 
with antidiabetic potential. Majority of these plants 
have been reported to possess bioactive compounds 
that affect various metabolic cascades, which in turn 
affects the level of blood glucose directly or indirectly 
(Grover and Vats, 2001).The diagnosis of diabetes 
mellitus depends solely on the demostration of 
hyperglycemia (Tietz, 2008). In this study, no 
significant change was observed in the fasting blood 
glucose concentration of the normal control rats when 
compared with the basal values whereas the diabetic 
control group demonstrated progressive significant 
(p<0.05) increases from day 1 (day treatment with 
plant extract commences) through 21.The diabetic 
treated group demonstrated progressive significant 
(p<0.05) decrease in fasting blood glucose from day 7-
21 (Table 1). Diabetes Mellitus (DM) is a common 
disorder associated with increased morbidity and 
mortality and can be defined as a group of metabolic 
diseases characterized by chronic hyperglycemia due 
to defective insulin secretion, insulin action, or both, 
resulting in impaired carbohydrate, lipid, and protein 
metabolism (Akahet al., 2009). The observed 
progressive significant increases in the fasting blood 
glucose of diabetic control rats in this study may be a 
result of low levels of insulin arising from effects of 
streptozotocin (STZ) on the pancreas of the rats. STZ 
potentiate dephosphorylation of ATP which leads to 
the generation of superoxide anions, hydrogen 
peroxides and hydroxyl radicals. This result to 
increase intracellular peroxides in the pancreatic islets, 
which may induce damage due to reactive oxygen 
species (Lenzen et al., 1996). The observed 
progressive increase in fasting blood glucose of the 
diabetic rats treated with the leaf extract of Guiera 
senegalensis may be that the plant was able to 
ameliorate the effect of STZ on the rats, possibly due 
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to the presence of bioactive compound with the 
capacity to scavenge free radicals. Pancreatic islet cells 
protection and regeneration of beta cells have been 
linked to the antioxidant capacity of flavonoids 
(Sabuet al., 2002). Mohammed (2013) has reported the 
presence of flavonoids in the plant. 
 
Body weight: The results of the weekly records of body 
weight of the experimental rats are presented in table 
2.0. Significant (p<0.05) increase was observed from 
day 1-21 and day 14-21 in normal control and diabetic-
treated rats respectively. The diabetic control rats 
showed reduction in body weight but the decrease was 
not significant when compared with the basal values. 
Decreased body weight, reduced insulin levels, 
hyperglycemia, etc are general characteristics of STZ-
induced diabetic rat (Ding et al., 2006). The observed 
improvement in body weight of the diabetic-treated 
group in this study may be that the plant extract was 
able to potentiate glycemic control and structural 
proteins synthesis (Balamurugan and Ignacimuthu, 
2011). 
 
Kidney function indices: Hyperglycaemia-induced 
oxidative stress in diabetes is a major cause for the 
development and progression of diabetic 
microvascular complications such as diabetic 
nephropathy (Kashiharaet. al., 2010). Kidneys are 
among the vital organs in the body, which eliminates 
urea, uric acid, creatinine etc., and also maintains the 
water balance to the optimal levels. In diabetes, the 
toxic concentration of blood glucose levels, damages 
the renal tissue, which lead to altered renal function, 
causing diabetic nephropathy (Aurell and Bjorck, 
1992). In this study, no significant change was seen in 
the levels of creatinine, urea, Cl‾, and HCO3−, in the 
diabetic control and diabetic-treated groups compared 
to the normal control group. However, Na+ and K+ 
levels were elevated in the diabetic control group 
relative to normal control. But extract of Guiera 
senegalensis brought these values to normal level 
(Table 3.0). Diabetes is associated with increased 
volume and metabolites excretions through the 
kidneys, usually in excess of normal thresholds. This 
often results to derangement in homeostatic balance 
with respect to electrolytes (Carlson, 1997). Metabolic 
acidosis is associated with hyperkalemia because 
increased hydrogen ions are available for sodium 
exchange in the renal tubules at the expense of 
potassium ions and hence result in increased retention 
of potassium in serum. The increased K+ observed in 
the diabetic control may be ascribed to metabolic 
acidosis resulting from low levels of insulin. 
Development of diabetes complications depends on 
the stage of progression of diabetes (Hira et al., 2018). 
The non-significant effect in the levels of creatinine, 
urea, Cl‾, and HCO3− may not be unconnected with the 
stage of progression of the disease. 
 
Table 1: Mean fasting blood glucose of diabetic rats administered aqueous leaf extract of Guiera senegalensis for 21 days 
 
   mg/dl   
Group Basal Day1 Day7 Day14 Day21 
Normal Control 79.00±8.03bc 65.00±4.76b 88.25 ± 4.92c 67.00±4.69b 83.00±3.32c 
Diabetes Control 72.50±12.87a 312.25±41.63b 546.75 ± 53.25c 522.00±46.00c 589.25±6.24c 
Diabetes Treated 79.25 ±4.09a 597.50±2.50b 402.50±32.12e 342.75±32.39de 297.75±30.77cd 
Values are expressed as fasting blood glucose concentration and means ± SEM of five independent determinations. Values in the same row 
with different superscript represent significant (p<0.05) difference from basal. 
 
Table 2: Mean body weight of diabetic rats administered aqueous leaf extract of Guiera senegalensis for 21 days 
 
Group 
  (g)   
Basal Day1 Day7 Day14 Day21 
Normal Control 134.68±2.61a 165.94±8.20b 171.95±6.10bc 184.97±4.41cd 193.76±5.25d 
Diabetes Control 128.56±4.62ab 132.43±5.43b 117.44±3.56ab 119.46±1.82a 117.73±4.53a 
Diabetes Treated 121.46±7.84a 124.56±4.52a 135.24±5.47ab 147.57±10.91b 158.56±16.23b 
Values are expressed as body weight and are means ± SEM of five independent determinations. Values in the same row with different 
superscript represent significant (p<0.05) difference from basal. 
 









K+ (mEq/L)  Na+  (mEq/L)  Urea (mg/dl)  
Normal Control 9.26±0.08a 74.8±0.49a 63.65±0.26a 3.72±0.01a 120.60±0.38a 9.11±0.37ab 
Diabetes Control 9.13±0.16a 73.2±0.48a 65.18±0.69a 3.95±0.06b 125.05±1.72b 9.92±0.32b 
Diabetes Treated 9.22±0.13a 73.1±0.72a 64.22±0.49a 3.74±0.04a 120.50±0.85a 8.84±0.15a 
Values are expressed as concentrations of kidney function and means ± SEM of five independent determinations. Values in the same column 
with different superscript represent significant (p<0.05) difference from the controls (normal and diabetic control). 
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 Unit/mg proteins  
SOD CAT GPX 
Normal Control 3.49±0.32ab 27.50±2.34a 27.81±2.79a 
Diabetes Control 2.99±0.48a 9.87±1.62b 21.87±1.23a 
Diabetes Treated 4.41±0.02b 49.93±3.95c 41.10±2.91b 
Values are expressed as anti-oxidants activity and means ± SEM of five independent determinations. Values in the same column with 
different superscript represent significant (p<0.05) difference from the controls (normal and diabetic control) 
 
Table 5: Mean serum concentrations of lipid profile of diabetic rats administered aqueous leaf extract of Guiera senegalensis for 21 days 
   mg/dl  
Group Total Cholesterol Triglycerides LDL-Cholesterol HDL-Cholesterol 
Normal Control 1.93±0.89a 0.83±0.06a 1.22±0.03a 0.59±0.29a 
Diabetes Control 2.52±0.03b 1.66±0.39b 1.33±0.18a 0.44±0.01b 
Diabetes Treated 2.14±0.05c 1.05±0.04ab 1.17±0.07a 0.49±0.02b 
Values are expressed as concentrations of lipid profile and are means ± SEM of five independent determinations. Values in the same column 
with different superscript represent significant (p<0.05) difference from the controls (normal control and diabetic control) 
 
Antioxidant enzymes: Decreased antioxidant enzyme 
levels and enhanced lipid peroxidation have been well 
documented in STZ-induced diabetes (Wang et al., 
2010). In this study, marginal decrease in the activities 
of SOD and GPX and significant (p<0.05) decrease in 
CAT activity were observed in diabetic control group 
compared to the normal control group. Whereas the 
diabetic treated group exhibited significant increase in 
the activity of all the antioxidant enzymes assayed in 
relation to normal and diabetic control groups (Table 
4.0). The observed reduction in antioxidant enzymes 
in diabetic control group in this study may be ascribed 
to the effects of hyperglycemia arising from STZ 
action. Hyperglycemia-induced superoxide 
overproduction inhibits glyceraldehydes 3-phosphate 
dehydrogenase (GAPDH) enzyme of the glycolytic 
pathway through the activation of poly (ADP-ribose) 
polymerase (PARP). This in turns results to increased 
levels of the glycolytic intermediates that are upstream 
of GAPDH. The resultant increase in intracellular 
glucose is reduced by aldose reductase via the polyol 
pathway, consuming NADPH, an important cofactor 
for regenerating critical intracellular antioxidants (Lee 
and Chung, 1999). Thus lowering the levels of 
intracellular antioxidant enzymes. The observed 
increased in the levels of the antioxidant enzymes in 
the diabetic-treated group may be attributed to the 
ability of the plant extract to lower blood glucose. 
 
Lipid profile: With the exception of LDL-cholesterol 
that had no significant change in all the groups, 
significant (p<0.05) increase were observed in the 
levels of total cholesterol and triglyceride in diabetic 
control group when compared with normal control 
whereas HDL-cholesterol level was significantly 
reduced.  Marginal and significant reduction of 
triglyceride and total cholesterol levels were 
respectively observed in the diabetic treated groups 
compared with the diabetic control group. Marginal 
increase was also observed in HDL-cholesterol level. 
Development of diabetes complications depends on 
the stage of progression of diabetes (Hira et al., 2018) 
and therapeutic effects of medicinal plants depends 
also on the stage of progression of diabetes as well as 
duration of treatment. The marginal effects of STZ in 
some of the analyzed lipids in the diabetic control 
group and the marginal effects of the plant extract in 
the diabetic treated group in this study may be 
connected to the stage of progression of the disease 
and duration of treatment. Dyslipidemia is one of the 
major risk factors for cardiovascular disease (CVD) in 
diabetes mellitus (Ira, 2011). The lowering of lipids 
exhibited by this plant suggests that the plant may be 
able to prevent CVD. 
 
Conclusion: Diabetes epidemic is on the increase and 
the search for newer pharmacological agents from 
natural products to combat this epidemic is 
encouraged. The findings from this study have 
demonstrated that leaf extract of Guiera senegalensis 
possesses antioxidant, lipid lowering and antidiabetic 
potential and may be a good candidate for diabetes 
management. However, further study is recommended 
to investigate long term effect of the plant in diabetic 
animals in addition to the assessment of other 
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